Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia.

Journal: Cell Stem Cell

Published: 2019-08-01

DOI: 10.1016/j.stem.2019.07.001

Affiliations: 22

Authors: 41

Go to article
Institutions Share
Australian Centre for Blood Diseases (ACBD), Monash University, Australia 0.21
Division of Molecular Medicine, WEHI, Australia 0.18
Department of Medical Biology, UniMelb, Australia 0.10
Division of Molecular Immunology, WEHI, Australia 0.06
Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec (BIOCEV), Czech Republic 0.05
Department of Biosystems Science and Engineering (D-BSSE), ETH Zurich, Switzerland 0.05
Division of Cancer and Haematology, WEHI, Australia 0.04
Peter MacCallum Cancer Centre (Peter Mac), Australia 0.04
Division of Hematology/Oncology, BCH, United States of America (USA) 0.04
Sir Peter MacCallum Department of Oncology, UniMelb, Australia 0.04
NYU Department of Pathology, United States of America (USA) 0.03
Baker Heart and Diabetes Institute (Baker IDI), Australia 0.02
Alfred Hospital, Australia 0.02
Department of Immunology and Pathology, Monash University, Australia 0.02
Collège de France, France 0.02
Molecular Pathology and Virology, IUH, France 0.02
Hôpital Saint-Louis, France 0.02
Harvard Department of Pediatrics, United States of America (USA) 0.01
St Vincent's Hospital Melbourne, Australia 0.01
Research Institute of Molecular Pathology (IMP), Austria 0.01
Medical University of Vienna (MUW), Austria 0.01
School of Mathematics and Statistics, UniMelb, Australia 0.01